GTC
IRWD icon

Ghost Tree Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ghost Tree Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-417,900
Closed -$4.22M – 87
2015
Q2 		$4.22M Buy
+417,900
New +$4.86M 1.37% 33

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Ghost Tree Capital's IRWD Position: Q3 2015 in Review

Ghost Tree Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2015, closing a stake of 417,900 shares — an estimated $4.22M sold.

Ghost Tree Capital first reported a position in IRWD in Q2 2015 and held it in 1 quarter. The position peaked at $4.22M in Q2 2015. 130 funds tracked by Wall St. Rank hold IRWD as of Q3 2015.

  • Ghost Tree Capital reported no remaining Ironwood Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Ghost Tree Capital sold 417,900 Ironwood Pharmaceuticals shares in Q3 2015, an estimated $4.22M.
  • Ghost Tree Capital first reported a position in Ironwood Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Ghost Tree Capital's Ironwood Pharmaceuticals position peaked at $4.22M in Q2 2015.
  • 130 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2015.

Based on Ghost Tree Capital's 13F filing for Q3 2015, filed 16 Nov 2015.